Hanan Alkhaldi

Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and IDH1 R132C mutation

Y. Ning, M. Baer, A. Emadi, 2022, Leukemia & lymphoma.

Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience.

D. Atanackovic, A. Rapoport, S. Dahiya, 2023, Transplantation proceedings.

Deep dissection of the antiviral immune profile of patients with COVID-19

T. Luetkens, D. Atanackovic, J. Baddley, 2021, Communications Biology.

Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant

T. Luetkens, D. Atanackovic, J. Baddley, 2021, Vaccines.

Safety and efficacy of immune checkpoint inhibitors after allogeneic hematopoietic cell transplantation

M. Aljurf, R. El Fakih, M. Kharfan-Dabaja, 2023, Bone Marrow Transplantation.

Myeloablative Haploidentical donor hematopoietic transplantation using post-transplant cyclophosphamide and antithymoglobulin.

N. Chaudhri, W. Rasheed, S. Ahmed, 2024, Transplantation and cellular therapy.